Citi Pharma partners with Indian-based pharma

News Image

MG News | July 02, 2024 at 11:23 AM GMT+05:00

0:00

July 02, 2024 (MLN): Citi Pharma Limited (PSX: CPHL) has entered into an agreement with Murli Krishna Pharma Private Ltd, a company incorporated and existing under the relevant laws of India.

The company shared the development in its notice to the Pakistan Stock Exchange (PSX) on Tuesday.

This exclusive strategic partnership aims to establish the terms and conditions under which Murli Krishna Pharma Private Ltd will supply high-quality Active Pharmaceutical Ingredients (APIs) and products exclusively to Citi Pharma Limited in the Pakistan market, it said.

Under the terms of this agreement, Murli Krishna agrees not to supply any of the APIs in N-l form (the form they will be supplying to CPHL) to any other company in Pakistan except Citi Pharma.

This exclusivity ensures that Citi Pharma Limited will have the sole right to market, distribute, and sell these exclusive products within Pakistan.

Murli Krishna Pharma Private Ltd is committed to supplying the Exclusive Products to Citi Pharma Limited in accordance with the highest quality standards in the pharmaceutical industry, complying with British Pharmacopoeia (BP) or United States Pharmacopeia (USP) standards, or as specified by our regulatory team.

"This commitment to quality and exclusivity is a significant milestone for both companies and underscores our dedication to providing the best pharmaceutical products to the market," the notice reads.

CPHL said that this agreement is anticipated to generate a turnover increase of Rs2.8 billion, with the cost of sales expected to rise by Rs2.38bn.

The increase in operational costs due to this agreement is projected to be minimal, as the company will be leveraging Citi Pharma's existing resources, it added.

Upon the successful completion of phase one of this agreement (the first two years), Citi Pharma Limited and Murli Krishna Pharma Private Ltd have agreed to discuss and negotiate the expansion of our supply chain to other countries, including but not limited to the USA and the Kingdom of Saudi Arabia.

"We are excited about this collaboration and the potential it holds for future growth and expansion.

This partnership not only strengthens our product portfolio but also reaffirms our commitment to delivering high-quality pharmaceutical products to our customers," it further added.

About Murli Krishna Pharma Private Ltd

Murli Krishna Pharma Private Ltd. is a 20-year-old Indian organization that provides a range of innovative solutions to optimize the delivery of pharmaceutical preparations.

Murli Krishna Pharma Private Ltd. has established itself as a key player in the pharmaceutical industry.

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 134,299.77
290.06M
0.39%
517.42
ALLSHR 84,018.16
764.12M
0.48%
402.35
KSE30 40,814.29
132.59M
0.33%
132.52
KMI30 192,589.16
116.24M
0.49%
948.28
KMIALLSHR 56,072.25
387.69M
0.32%
180.74
BKTi 36,971.75
19.46M
-0.05%
-16.94
OGTi 28,240.28
6.19M
0.21%
58.78
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 118,140.00 119,450.00
115,635.00
4270.00
3.75%
BRENT CRUDE 70.63 70.71
68.55
1.99
2.90%
RICHARDS BAY COAL MONTHLY 97.50 0.00
0.00
1.10
1.14%
ROTTERDAM COAL MONTHLY 108.75 108.75
108.75
0.40
0.37%
USD RBD PALM OLEIN 998.50 998.50
998.50
0.00
0.00%
CRUDE OIL - WTI 68.75 68.77
66.50
2.18
3.27%
SUGAR #11 WORLD 16.56 16.60
16.20
0.30
1.85%

Chart of the Day


Latest News
July 11, 2025 at 10:56 PM GMT+05:00

Gold price in Pakistan rises Rs2,300 per tola


July 11, 2025 at 05:49 PM GMT+05:00

PKR gains 10 paisa per USD


July 11, 2025 at 05:41 PM GMT+05:00

PSX Closing Bell: Bulls Serenade The Bourse


July 11, 2025 at 05:06 PM GMT+05:00

UBL doubles profit to Rs65bn in 1HCY25


July 11, 2025 at 04:19 PM GMT+05:00

Ideal Spinning Mills to exit spinning business



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg